Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / Class A Stock
-
Shares outstanding
-
115M
-
Number of holders
-
476
-
Total 13F shares, excl. options
-
114M
-
Shares change
-
+4.85M
-
Total reported value, excl. options
-
$6.73B
-
Value change
-
+$196M
-
Put/Call ratio
-
0.05
-
Number of buys
-
258
-
Number of sells
-
-240
-
Price
-
$59.02
Significant Holders of GLOBUS MEDICAL INC - Class A Stock (GMED) as of Q2 2025
580 filings reported holding GMED - GLOBUS MEDICAL INC - Class A Stock as of Q2 2025.
GLOBUS MEDICAL INC - Class A Stock (GMED) has 476 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 114M shares
of 115M outstanding shares and own 98.97% of the company stock.
Largest 10 shareholders include BlackRock, Inc. (10.8M shares), VANGUARD GROUP INC (10.7M shares), JANUS HENDERSON GROUP PLC (8.21M shares), Burgundy Asset Management Ltd. (3.48M shares), STATE STREET CORP (3.47M shares), JPMORGAN CHASE & CO (3.34M shares), Sculptor Capital LP (2.76M shares), WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC (2.41M shares), HAWK RIDGE CAPITAL MANAGEMENT LP (2.12M shares), and GENEVA CAPITAL MANAGEMENT LLC (2.08M shares).
This table shows the top 476 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.